Increasing the serum persistence of an IgG fragment by random mutagenesis
- PMID: 9219265
- DOI: 10.1038/nbt0797-637
Increasing the serum persistence of an IgG fragment by random mutagenesis
Abstract
The major histocompatibility complex (MHC) class I-related receptor FcRn is involved in regulating serum gammaglobulin (IgG) levels in mice. With the aim of increasing the serum half-life of a recombinant murine Fc gamma 1 fragment, the affinity for binding to FcRn at pH 6.0 has been increased by random mutagenesis of Thr252, Thr254, and Thr256 followed by selection using bacteriophage display. These residues were chosen as they are in proximity to the FcRn-IgG (Fc) interaction site. Two mutants with higher affinity (due to lower off-rates) than the wild-type Fc have been isolated and analyzed in pharmacokinetic studies in mice. The mutant with the highest affinity has a significantly longer serum half-life than the wild type fragment, despite its lower off-rate from FcRn at pH 7.4. The results provide support for the involvement of FcRn in the homeostasis of serum IgGs in mice. The indications that a homologous FcRn regulates IgG levels in humans suggest that this approach has implications for increasing the serum persistence of therapeutic antibodies.
Similar articles
-
Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice.Eur J Immunol. 1996 Mar;26(3):690-6. doi: 10.1002/eji.1830260327. Eur J Immunol. 1996. PMID: 8605939
-
Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1.J Immunol. 1997 Mar 1;158(5):2211-7. J Immunol. 1997. PMID: 9036967
-
Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.J Immunol. 2010 Feb 15;184(4):1968-76. doi: 10.4049/jimmunol.0903296. Epub 2010 Jan 18. J Immunol. 2010. PMID: 20083659
-
Perspective-- FcRn transports albumin: relevance to immunology and medicine.Trends Immunol. 2006 Jul;27(7):343-8. doi: 10.1016/j.it.2006.05.004. Epub 2006 May 30. Trends Immunol. 2006. PMID: 16731041 Review.
-
FcRn: the neonatal Fc receptor comes of age.Nat Rev Immunol. 2007 Sep;7(9):715-25. doi: 10.1038/nri2155. Epub 2007 Aug 17. Nat Rev Immunol. 2007. PMID: 17703228 Review.
Cited by
-
The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding.Int J Mol Sci. 2021 Mar 13;22(6):2922. doi: 10.3390/ijms22062922. Int J Mol Sci. 2021. PMID: 33805757 Free PMC article. Review.
-
Extended plasma half-life of albumin-binding domain fused human IgA upon pH-dependent albumin engagement of human FcRn in vitro and in vivo.MAbs. 2021 Jan-Dec;13(1):1893888. doi: 10.1080/19420862.2021.1893888. MAbs. 2021. PMID: 33691596 Free PMC article.
-
Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions.J Immunol. 2015 Jun 1;194(11):5497-508. doi: 10.4049/jimmunol.1401218. Epub 2015 Apr 22. J Immunol. 2015. PMID: 25904551 Free PMC article.
-
Structure-based engineering of pH-dependent antibody binding for selective targeting of solid-tumor microenvironment.MAbs. 2020 Jan-Dec;12(1):1682866. doi: 10.1080/19420862.2019.1682866. MAbs. 2020. PMID: 31777319 Free PMC article.
-
Therapeutic antibodies for autoimmunity and inflammation.Nat Rev Immunol. 2010 May;10(5):301-16. doi: 10.1038/nri2761. Nat Rev Immunol. 2010. PMID: 20414204 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials